📰 Daniel De Roulet News
Daniel De Roulet News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel De Roulet. Real-time updates on events, politics, business and more.
October 5, 2023
/PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has exercised its exclusive right and completed the acquisition of Mitokinin, a discovery-stage...
October 5, 2023
Biopharma major AbbVie Inc. (ABBV) announced on Thursday that it had exercised its exclusive right and completed the acquisition of Mitokinin, a biotechnology company.
March 3, 2021
AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset Company can acquire asset following the completion of IND enabling studies AbbVie has purchased an exclusive right to acquire Mitokinin’s lead PINK1 asset following the completion of IND enabling studies for Parkinson’s disease. Mitokinin is based on technology discovered at the University of California, San Francisco (UCSF) by company co-founders Nicholas Hertz and Kevan Shokat. Hertz and Shokat moved the company int...
March 2, 2021
Share this article Share this article SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- Mitokinin, Inc., a biotechnology company developing PINK1-targeted therapeutics for the treatment of neurodegenerative diseases, announced today that AbbVie, a leading global biopharmaceutical company, has purchased an exclusive right to acquire Mitokinin following completion of IND enabling studies on Mitokinins lead PINK1 compound. Based on technology discovered at UCSF by Mitokinin co-founders Nicholas Hertz ...